Celldex Therapeutics, Inc.
METHODS OF TREATING CANCER WITH DENDRITIC CELL MOBILIZING AGENTS
Last updated:
Abstract:
Methods of treating cancer comprising administering to patients a dendritic cell mobilizing agent (e.g., Flt3 ligand) in combination with radiation and/or immunoregulatory agents (e.g., checkpoint inhibitors), are disclosed.
Status:
Application
Type:
Utility
Filling date:
25 Jan 2019
Issue date:
18 Mar 2021